Stephen D Wiviott

8PUBLICATIONS
70CO-AUTHORS
Cardiology (incl. cardiovascular diseases)Gene and molecular therapyPredictive and prognostic markersExercise physiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Aug 30, 2025
Dapagliflozin in Patients Hospitalized for Heart Failure: Primary Results of the DAPA ACT HF-TIMI 68 Randomized Clinical Trial and Meta-Analysis of Sodium-Glucose Cotransporter-2 Inhibitors in Patients Hospitalized for Heart Failure.

David D Berg, Siddharth M Patel, Paul M Haller

|Apr 07, 2024
Sodium-Glucose Cotransporter-2 Inhibitors and Major Adverse Cardiovascular Outcomes: A SMART-C Collaborative Meta-Analysis.

Siddharth M Patel, Yu Mi Kang, KyungAh Im

|Feb 13, 2023
Association Between Achieved Low-Density Lipoprotein Cholesterol Levels and Long-Term Cardiovascular and Safety Outcomes: An Analysis of FOURIER-OLE.

Prakriti Gaba, Michelle L O'Donoghue, Jeong-Gun Park

|Aug 29, 2022
Anticoagulation and Antiplatelet Therapy for Prevention of Venous and Arterial Thrombotic Events in Critically Ill Patients With COVID-19: COVID-PACT.

Erin A Bohula, David D Berg, Mathew S Lopes

|Aug 29, 2022
Long-Term Evolocumab in Patients With Established Atherosclerotic Cardiovascular Disease.

Michelle L O'Donoghue, Robert P Giugliano, Stephen D Wiviott

|May 05, 2022
Efficacy and Safety of Dapagliflozin in Type 2 Diabetes According to Baseline Blood Pressure: Observations From DECLARE-TIMI 58 Trial.

Remo H M Furtado, Itamar Raz, Erica L Goodrich

Pageof 2

Frequent Collaborators

8 joint publications

Marc S Sabatine

4 joint publications

Michelle L O'Donoghue

3 joint publications

Darren K McGuire

2 joint publications

Hiddo J L Heerspink